Gabapentin in antipsychotic-induced tardive dyskinesia: Results of 1-year follow-up

Journal of Affective Disorders

Volumn 75, Issue 2, 2003, Pages 125-130

  Hardoy, Maria Carolina ^a   Carta, Mauro Giovanni ^a   Carpiniello, Bernardo ^a   Cianchetti, Carlo ^a   Congia, Socrate ^a   D'Errico, Immacolata ^b   Emanuelli, Guido ^c   Garonna, Franco ^c   Hardoy, Maria Julieta ^d   Nardini, Marcello ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c Department of Psychiatry ^*  (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Affective disorders; Anticonvulsants; Atypical antipsychotics; Gabapentin; Movement disorders; Tardive dyskinesia

Indexed keywords

GABAPENTIN;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; CONFUSION; DRUG EFFICACY; DYSPHORIA; FEMALE; FOLLOW UP; HUMAN; IRRITABILITY; ITALY; MALE; MENTAL HEALTH CENTER; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; SAMPLING; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SEDATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TARDIVE DYSKINESIA; TREATMENT OUTCOME; VERTIGO; WEIGHT GAIN;

EID: 0037716604     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00043-5     Document Type: Article

References (18)

1. Alexander, B., Lund, B.C., 1999. Tardive dyskinesia. Clinical Psychopharmacology Seminar, Virtual Hospital, www.vh.org/providers, University of Iowa.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition:1994;American Psychiatric Association, Washington, DC.
3. Beasley C.M., Dellva M.A., Tamura R.N. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. Br. J. Psychiatry. 174:2000;23-30.
4. Bloom F.E., Kupfer D.J. Psychopharmacology. The Fourth Generation of Progress. 1995;Raven Press, New York.
5. Carta, M.G., Angius, G., Hardoy, M.C., Lampis, D., Maccioni, F., Masia, M., Mazzella, D., Pes, A., Spagnesi, A., Zedda, C., Carpiniello, B., 2000. Farmacoterapia e riabilitazione: quale integrazione? L'utilizzo dei farmaci antipsicotici in cinque centri di salute mentale in Sardegna. Societá Italiana di liabilitazione Psicosociale. VI Congresso Nazionale. Montecatini Terme, Pistoia, Poster.
6. Casey D.E. Affective disorders and tardive dyskinesia. Encephale. 14:1988;221-226.
7. Chiò A., Scanzio V. Scale Di Valutazione in Neurologia. 1998;Centro Scientifico Editore, Torino.
8. 2 delta subunit of a calcium channel. J. Biol. Chem. 271:1996;5768-5776.
9. Guy W. ECDEU Assessment Manual For Psychopharmacology. Revised. 1976;534-537 Public Health Service, US Government Printing Office, Washington D.C. US Department of Health, Education and Welfare Publication, No. 76-338.
10. Hardoy M.C., Hardoy M.J., Carta M.G., Cabras P.L. Gabapentin as a promising treatment for antipsychotic-induced movement disorders in schizoaffective and bipolar patients. J. Affect. Disord. 54:1999;315-317.
11. Kane J.M., Jeste D.V., Barnes T.R.E., et al. Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. 1992;American Psychiatric Association, Washington, DC.
12. Kumar S., Malone D.M. Risperidone implicated in the onset of tardive dyskinesia in a young woman. Postgrad. Med. J. 76:(895):2000;316-317.
13. Lykouras L. Two cases of risperidone induced tardive dyskinesia and a review of the literature. Eur. Psychiatry. 14:1999;245-247.
14. McGrath J.J., Soares K.V. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. Cochrane Database Syst. Rev. 2:2000;CD000459.
15. Modestin J., Stephan P.L., Erni T., Umari T. Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine treatment to tardive dyskinesia. Schizophr. Res. 42:(3):2000;223-230.
16. Rosenheck R., Cramer J., Xu W., Thomas J., Henderson W., Frisman L., Fye C., Charney D. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. New Engl. J. Med. 337:(12):1997;809-815.
17. Soares K.V., McGrath J.J. The treatment of tardive dyskinesia - a systematic review and meta-analysis. Schizophr. Res. 39:(1):1999;1-18.
18. Soares K.V., McGrath J.J., Deeks J.J. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst. Rev. 2:2000;CD000203.